Abstract

Simple SummaryPhysiological changes to the body can affect the brain. For example, inflammation that originates in the body can be sensed by the brain. In this study, we used an agent called resiquimod (R848) to stimulate inflammation in the periphery and measured structural and metabolic brain responses in anesthetized mice using in vivo magnetic resonance imaging. Relative to baseline prior to drug administration, a high dose of R848 caused sickness behaviors and volume expansion in several cortical regions at 3 h that were no longer evident at 24 h. Transient volume expansion in response to peripheral immune stimulation is consistent with brain swelling.Peripheral administration of the E. coli endotoxin lipopolysaccharide (LPS) to rats promotes secretion of pro-inflammatory cytokines and in previous studies was associated with transient enlargement of cortical volumes. Here, resiquimod (R848) was administered to mice to stimulate peripheral immune activation, and the effects on brain volumes and neurometabolites determined. After baseline scans, 24 male, wild-type C57BL mice were triaged into three groups including R848 at low (50 μg) and high (100 μg) doses and saline controls. Animals were scanned again at 3 h and 24 h following treatment. Sickness indices of elevated temperature and body weight loss were observed in all R848 animals. Animals that received 50 μg R848 exhibited decreases in hippocampal N-acetylaspartate and phosphocreatine at the 3 h time point that returned to baseline levels at 24 h. Animals that received the 100 μg R848 dose demonstrated transient, localized, volume expansion (~5%) detectable at 3 h in motor, somatosensory, and olfactory cortices; and pons. A metabolic response evident at the lower dose and a volumetric change at the higher dose suggests a temporal evolution of the effect wherein the neurochemical change is demonstrable earlier than neurostructural change. Transient volume expansion in response to peripheral immune stimulation corresponds with previous results and is consistent with brain swelling that may reflect CNS edema.

Highlights

  • IntroductionImmune responses to potential pathogens are generally determined by engagement of specific pattern recognition receptors such as Toll-like, NOD-like, RIG-I-like, and C-type lectin receptors [1]

  • Activation of TLR7/8 receptors is associated with cytotoxic T-cell responses, concomitant blocking of immunosuppressive cells [3,4,5,6,7], and upregulation of genes involved in inflammation such as pro-inflammatory cytokines (TNFα, IL6) [8] and type I interferons (IFN) [9,10,11,12]

  • Older literature suggests that TLR7 is present in a variety of CNS cell types, including neurons [13,14]

Read more

Summary

Introduction

Immune responses to potential pathogens are generally determined by engagement of specific pattern recognition receptors such as Toll-like, NOD-like, RIG-I-like, and C-type lectin receptors [1]. Toll-like receptors (TLRs) play a critical role in innate immunity [2]. Activation of TLR7/8 receptors is associated with cytotoxic T-cell responses, concomitant blocking of immunosuppressive cells [3,4,5,6,7], and upregulation of genes involved in inflammation such as pro-inflammatory cytokines (TNFα, IL6) [8] and type I interferons (IFN) [9,10,11,12]. Older literature suggests that TLR7 is present in a variety of CNS cell types, including neurons [13,14]. Suggest preferential TLR7 distribution to microglia [15,16]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call